Receptor Biologix
Palo Alto
About Receptor Biologix
Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases. The company is headquartered in Palo Alto, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2005)
- Website: receptorbiologix.com
- Phone: +1 650-266-4600
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/receptor-biologix-462280 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.